Atara Biotherapeutics (ATRA) PT Raised to $32 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts ATRA Hot Sheet
Price: $9.02 +1.35%
Rating Summary:
5 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
5 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
H.C. Wainwright analyst Robert Burns raised the price target on Atara Biotherapeutics (NASDAQ: ATRA) to $32.00 (from $31.00) while maintaining a Buy rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Ultrapar Participacoes SA (UGPA3:BZ) (UGP) PT Raised to BRL39 at JPMorgan
- Science Applications (SAIC) PT Raised to $123 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
